Cytokinetics Inc. buy Royal Bank of Canada
Start price
18.12.24
/
50%
€45.80
Target price
18.12.25
€78.17
Performance (%)
20.09%
Price
02.12.25
€55.00
Summary
This prediction is currently active. The prediction currently has a performance of 20.09%. This prediction currently runs until 18.12.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -5.983% | -5.983% |
| iShares Core DAX® | 0.697% | -0.987% |
| iShares Nasdaq 100 | 1.661% | -1.837% |
| iShares Nikkei 225® | 0.922% | -7.458% |
| iShares S&P 500 | 0.430% | -0.851% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target raised by analysts at Royal Bank of Canada from $80.00 to $82.00. They now have an "outperform" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€55.50
11.11.25
11.11.25
€75.30
11.11.26
11.11.26
-0.90%
02.12.25
02.12.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.40
07.05.25
07.05.25
€70.52
07.05.26
07.05.26
87.07%
02.12.25
02.12.25